4.3 Dressing Categories, Formulary, and Resource Fit

Categories Are Just Functions With Labels

The Treatment blueprint pairs "dressing and resource recommendations" with "product categories and functions." Resource is not filler: a dressing plan must work in the actual setting (acute, home health, long-term care, outpatient) where the patient receives care, and within payer and formulary limits.

Memorize categories by what they do, plus one key caution each.

A few high-yield pairings the exam loves to invert: alginate on a dry wound (wrong, it desiccates), film over heavy exudate (wrong, it leaks and macerates), and hydrocolloid over a clinically infected wound (wrong, occlusion can worsen infection).

Know each category's special properties too. Hydrocolloids and films are occlusive and therefore support autolytic debridement, but that same occlusion is what makes them unsafe over infection. Calcium alginates have mild hemostatic action, which makes them useful after sharp debridement on a wound that oozes. Foams come in adhesive and nonadhesive forms, and bordered silicone foams reduce removal trauma on fragile skin. Collagen products supply a scaffold that can jump-start a stalled but viable wound, but they do nothing for dry eschar that has not yet been debrided.

Formulary, Payer, and the "Advanced Is Not Always Appropriate" Trap

Formulary questions test judgment, not memorization. When two products perform the same function, the available product that meets policy and cost limits is usually the better recommendation. When the on-formulary product cannot meet the wound's need, the WCC role is to communicate the clinical rationale for an alternate through the proper process, not to improvise outside orders.

Antimicrobial dressings are common distractors. Silver, cadexomer iodine, polyhexamethylene biguanide (PHMB), and medical-grade honey are appropriate when local bioburden or infection is a concern and policy supports use. They are not automatically required for every chronic wound, and silver in particular should be reassessed (commonly around a 2-week checkpoint) rather than continued reflexively. Many silver products are also not recommended during MRI or radiation therapy, a detail that occasionally appears.

Applied Scenario

A home-health patient has a moderately draining, shallow wound, fragile periwound skin, limited caregiver help, and a payer cap on supply quantity. The best answer is not the most complex product. It is the plan that matches the exudate (an absorptive foam), protects the skin (a barrier film), can be changed safely and infrequently by the available caregiver, is obtainable under the payer limit, and follows the provider's order.

• Step 1: Name the function (moisture, absorption, fill, protection, atraumatic, antimicrobial).
• Step 2: Confirm the patient, setting, formulary, and policy allow consistent use.
• Trap: occlusive products over untreated infection, heavy exudate, or dry ischemic eschar.
• Trap: ignoring removal injury. A dressing that controls drainage but strips skin or bleeds at each change is the wrong fit; weigh securement, adhesive sensitivity, location, and change-related pain.

This two-step approach (function, then feasibility) resolves the large majority of dressing-category items on the WCC exam.

Negative Pressure and Advanced Therapies

When a stem describes a large, deep, heavily draining wound with dead space, negative pressure wound therapy (NPWT) may appear as an option. NPWT applies controlled subatmospheric pressure to remove exudate, reduce edema, promote granulation, and approximate edges. It is contraindicated over untreated osteomyelitis, malignancy in the wound, exposed vessels or organs, and necrotic tissue with eschar that has not been debrided, and it requires intact periwound skin for the seal. The WCC role is to recognize candidacy and contraindications and to coordinate the ordered plan, not to initiate advanced therapy independently.

Similarly, products like medical-grade honey and cadexomer iodine carry both an antimicrobial and an autolytic-debriding action, which can make them attractive on a sloughy, malodorous wound, but honey is osmotic and will increase exudate volume initially, so the dressing plan must account for that extra drainage. The recurring theme across the formulary is the same: every advanced product earns its place only by matching the wound's current need, the care setting, and the patient's ability to use it safely and consistently.